Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Bate

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
JAMA Oncology|August 23, 2019
Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational BurdenDavid Bomze, Omar Hasan Ali, Andrew Bate, et al.
British Journal of Clinical Pharmacology|September 11, 2009
Rhabdomyolysis a result of azithromycin and statins: an unrecognized interactionJohanna Strandell, Andrew Bate, Staffan Hägg, et al.
Drug Safety|March 23, 2011
Dose variations associated with formulations of NSAID prescriptions for children: a descriptive analysis of electronic health records in the UKKristina Star, Ola Caster, Andrew Bate, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 2, 2010
Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern?Kristina Star, Andrew Bate, Ronald Hb Meyboom, et al.
Drug Safety|October 9, 2008
Impact of stratification on adverse drug reaction surveillanceJohan Hopstadius, G Niklas Norén, Andrew Bate, et al.
Drug Safety|November 26, 2008
Stratification for spontaneous report databasesJohan Hopstadius, G Niklas Norén, Andrew Bate, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 23, 2026
Ontology-based Semantic Similarity Measures for Clustering Medical Concepts in Drug SafetyJeffery L Painter, François Haguinet, Gregory E Powell, et al.
Drug Safety|August 2, 2019
A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis ToolRachel E Sobel, William Blackwell, David M Fram, et al.
Drug Safety|May 20, 2025
The Role of Adverse Event Follow-Up in Advancing the Knowledge of Medicines and Vaccines Safety: A Scoping ReviewVijay Kara, Florence Van Hunsel, Andrew Bate, et al.
Statistics in Medicine|March 18, 2008
A statistical methodology for drug-drug interaction surveillanceG Niklas Norén, Rolf Sundberg, Andrew Bate, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
JAMA Oncology|August 23, 2019
Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational BurdenDavid Bomze, Omar Hasan Ali, Andrew Bate, et al.
British Journal of Clinical Pharmacology|September 11, 2009
Rhabdomyolysis a result of azithromycin and statins: an unrecognized interactionJohanna Strandell, Andrew Bate, Staffan Hägg, et al.
Drug Safety|March 23, 2011
Dose variations associated with formulations of NSAID prescriptions for children: a descriptive analysis of electronic health records in the UKKristina Star, Ola Caster, Andrew Bate, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 2, 2010
Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern?Kristina Star, Andrew Bate, Ronald Hb Meyboom, et al.
Drug Safety|October 9, 2008
Impact of stratification on adverse drug reaction surveillanceJohan Hopstadius, G Niklas Norén, Andrew Bate, et al.
Drug Safety|November 26, 2008
Stratification for spontaneous report databasesJohan Hopstadius, G Niklas Norén, Andrew Bate, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 23, 2026
Ontology-based Semantic Similarity Measures for Clustering Medical Concepts in Drug SafetyJeffery L Painter, François Haguinet, Gregory E Powell, et al.
Drug Safety|August 2, 2019
A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis ToolRachel E Sobel, William Blackwell, David M Fram, et al.
Drug Safety|May 20, 2025
The Role of Adverse Event Follow-Up in Advancing the Knowledge of Medicines and Vaccines Safety: A Scoping ReviewVijay Kara, Florence Van Hunsel, Andrew Bate, et al.
Statistics in Medicine|March 18, 2008
A statistical methodology for drug-drug interaction surveillanceG Niklas Norén, Rolf Sundberg, Andrew Bate, et al.
Pageof 11